Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [8043]

C1ORF122: A novel diagnostic and prognostic biomarker in HCC

C1ORF122: A novel diagnostic and prognostic biomarker in HCC

PFAS disrupt healthy function in human liver cells

PFAS disrupt healthy function in human liver cells

Lung cancer rewires immune cells in the bone marrow to weaken body’s defenses

Lung cancer rewires immune cells in the bone marrow to weaken body’s defenses

'Bottlebrush' particles deliver big chemotherapy directly to cancer cells

'Bottlebrush' particles deliver big chemotherapy directly to cancer cells

Predicting where deadly brain cancer may spread next

Predicting where deadly brain cancer may spread next

WCLC 2025: Novel immunotherapy strategy shows promising long-term survival in advanced NSCLC patients with inadequate response to immune checkpoint inhibitors

WCLC 2025: Novel immunotherapy strategy shows promising long-term survival in advanced NSCLC patients with...

WCLC 2025: Circulating tumour DNA may guide immunotherapy use in limited-stage SCLC, new study shows

WCLC 2025: Circulating tumour DNA may guide immunotherapy use in limited-stage SCLC, new study shows

WCLC 2025: New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer

WCLC 2025: New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer

WCLC 2025: PALOMA-2 study: Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR-mutated NSCLC

WCLC 2025: PALOMA-2 study: Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR...

FDA approves gemcitabine intravesical system for non-muscle invasive bladder cancer

FDA approves gemcitabine intravesical system for non-muscle invasive bladder cancer

More from ecancer